WTG
IRMD icon

West Tower Group’s iRadimed IRMD Stock Holding History

West Tower Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,467
Closed -$117K – 298
2023
Q4 		$117K Buy
2,467
+1,204
+95% +$50.6K 0.24% 59
2023
Q3 		$56K Sell
1,263
-1,041
-45% -$48.4K 0.03% 169
2023
Q2 		$110K Buy
+2,304
New +$104K 0.08% 96

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

West Tower Group's IRMD Position: Q1 2024 in Review

West Tower Group sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 2,467 shares — an estimated $117K sold.

West Tower Group first reported a position in IRMD in Q2 2023 and held it in 3 quarters. The position peaked at $117K in Q4 2023. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.

  • West Tower Group reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 2,467 iRadimed shares in Q1 2024, an estimated $117K.
  • West Tower Group first reported a position in iRadimed in Q2 2023 and held it in 3 quarters.
  • West Tower Group's iRadimed position peaked at $117K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.